Alemtuzumab and rituximab

DRUG2 trials

Sponsors

Hospital Universitario Dr. Jose E. Gonzalez

Conditions

Aplastic AnemiaGraft vs Host Disease

Unknown Phase

Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease

CompletedNCT01042509

Hospital Universitario Dr. Jose E. GonzalezGraft vs Host Disease

Start: 2009-10-31End: 2012-01-31Updated: 2017-02-01

Alemtuzumab and Rituximab in Aplastic Anemia

WithdrawnNCT01408342

Hospital Universitario Dr. Jose E. GonzalezAplastic Anemia

Start: 2011-07-31End: 2014-01-31Updated: 2014-01-07

Related Papers

Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease.

2011-12-0117 citations